Dr. David Seifer, MD

• Reproductive Endocrinology & Infertility

• Obstetrics & Gynecology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Yale University

  Fellowship Hospital

• Stanford University Hospital

  Residency Hospital

• University Of Illinois

  Medical School

• Los Angeles County - Usc Medical Center

  Internship Hospital, 1982

• Usc Lac

  Internship Hospital, 1982

• English

• Spanish

• In Vitro Gametogenesis in Oncofertility: A Review of Its Potential Use and Present-Day Challenges in Moving toward Fertility Preservation and Restoration, 2023-05-06

• Do state insurance mandates alter ICSI utilization?, 2020-04-25

• Impact of CD4+ Lymphocytes and HIV Infection on Anti-Mullerian Hormone Levels in a Large Cohort of HIV-infected and -uninfected Women, 2014-10-23

• Circulating Vitamin D Correlates with Serum Anti-Mullerian Hormone Levels in Late Reproductive-Aged Women: Women's Interagency HIV Study, 2012-04-10

• Psychological experience and coping strategies of patients in the Northeast US delaying care for infertility during the COVID-19 pandemic, 2021-02-23

• High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology, 2020-03-10

• Women with PCOS who undergo IVF: a comprehensive review of therapeutic strategies for successful outcomes, 2023-08-01

• Impact of in vitro fertilization state mandates for third party insurance coverage in the United States: a review and critical assessment, 2022-08-04

• Preeclampsia at delivery is associated with lower serum vitamin D and higher antiangiogenic factors: a case control study, 2022-01-06

• Successful Same-Cycle Blastocyst Transfer following Laparoscopic Ovarian Detorsion: A Report of Two Cases and Literature Review, 2014-04-29

• Assisted Hatching and Intracytoplasmic Sperm Injection are not Associated with Improved Outcomes in ART Cycles for Diminished Ovarian Reserve: An Analysis of US Cycles from 2004-2011, 2014-07-30

• Correction to: Status of racial disparities between black and white women undergoing assisted reproductive technology in the US, 2021-07-30

• Differences in ICSI utilization rates among states with insurance mandates for ART coverage, 2021-11-30

• Angiopoietin-1 and angiopoietin-2 are altered in polycystic ovarian syndrome (PCOS) during controlled ovarian stimulation, 2013-10-24

• AMH predicts miscarriage in non-PCOS but not in PCOS related infertility ART cycles, 2023-04-05

• Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulation, 2014-08-20

• Correction to: Status of racial disparities between black and white women undergoing assisted reproductive technology in the US, 2020-12-21

• Vitamin D3 Regulates Follicular Development and Intrafollicular Vitamin D Biosynthesis and Signaling in the Primate Ovary, 2018-11-14

• AMH independently predicts aneuploidy but not live birth per transfer in IVF PGT-A cycles, 2023-02-04

• Diagnosis and Treatment of Diminished Ovarian Reserve in ART Cycles of Women Up to Age 40 Years: The Role of Insurance Mandates, 2012-10-23

• Potential Mechanisms for Racial and Ethnic Differences in Antimullerian Hormone and Ovarian Reserve, 2013-11-21

• CHANGES IN PLASMA MULLERIAN INHIBITING SUBSTANCE AND BRAIN-DERIVED NEUROTROPHIC FACTOR AFTER CHEMOTHERAPY IN PREMENOPAUSAL WOMEN, 2010-11-23